[1]
2026. SGLT2 INHIBITORS BEYOND GLYCEMIC CONTROL: CARDIORENAL PROTECTION MECHANISMS IN TYPE 2 DIABETES MELLITUS . MEDICINE, PEDAGOGY AND TECHNOLOGY: THEORY AND PRACTICE. 4, 9 (Sep. 2026), 62–64.